Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Largest Diet and Exercise Trial in the World for Type 2 Diabetes

27.07.2004


A massive grant of almost a million pounds has been awarded to the University of Bristol to carry out a major trial that will assess the effects of diet and exercise on people with type 2 diabetes. This trial will be the largest diet and exercise trial in the world for people with type 2 diabetes.



The recent large rise in the number of people suffering from type 2 diabetes is closely linked to the increase in obesity within the population, and this is thought to be due to a lack of exercise and an increase in food intake. Although we know a lot about how diet can control glucose levels and improve blood pressure and cholesterol, very little is known about how, or if, exercise affects these factors. This study aims to definitively answer these questions for the first time.

Dr Robert Andrews from the University of Bristol, who will lead the trial, said: “This is the largest exercise trial to be conducted in this country, and the largest exercise trial in the world for people with type 2 diabetes. We feel it will be a land mark trial from which crucial information on long-term glucose control, insulin sensitivity, insulin resistance, weight and blood pressure will emerge, allowing us to compare the effects of these conditions in each of the groups”.


The trial aims to recruit 750 people from across the Southwest who have been newly diagnosed with type 2 diabetes. Individuals will be allocated to one of three groups. Those in the first group will receive regular help and advice on improving their diet, the second group will receive the same dietary advice, but in addition they will receive help to increase their daily levels of exercise. The control group will receive the usual care.

Dr Ashley Cooper, also from the University of Bristol, said: “Participants in the exercise group will wear activity monitors all day every day. As they walk around and go about their daily business, these instruments will monitor just how many calories they are burning. Participants will be set targets to aim for so that they gradually increase the amount of exercise they do”.

Individuals will be recruited onto the trial within five months of being diagnosed and will remain in the trial for a year. The trial itself will run for three years.

Type 2 diabetes, previously known as ‘adult-onset diabetes’, commonly starts in adulthood, after the age of 30. In the last 30 years the number of people with type 2 diabetes has trebled and a further trebling in the number of patients is expected in the next ten years. This huge rise is closely linked to the recent increase in obesity within the population and threatens to be a major health problem in the future, if people cannot be persuaded to change their life styles.

Diabetes is a condition where the body can no longer control its blood sugar level. Without adequate control the level tends to rise dramatically and remains high. Over time, these high levels can result in damage to blood vessels leading to heart disease, stroke, blindness, kidney failure, impotence, circulatory problems and nerve damage.

The trial will be launched in November 2004. ‘Education days’ will be set up and doctors’ surgeries across the Southwest, from Gloucester to Taunton, will be able to refer patients newly diagnosed with type 2 diabetes to an education day. Patients attending these days will be given information about the study and be offered the opportunity to enter the trial.

The programme is a joint study between three departments at the University of Bristol. Drs Robert Andrews and Ashley Cooper in the Department of Exercise and Health Sciences, Dr Colin Dayan from Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, and Dr Alan Montgomery and Professors Tim Peters and Debbie Sharp in Primary Health Care. The grant from Diabetes UK (£240,000) is supported by a further £680,000 from the Department of Health.

| newswise
Further information:
http://www.bris.ac.uk

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>